CD34 and leukemia: Functionally, authors showed a significant effect of STM2457 in reducing clonogenic potential and inducing apoptosis in human and mouse AML model without affecting normal human cord blood (CD34+/HSPCs) and non-leukaemia (HPC7) hematopoietic cells [48].